SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-042996
Filing Date
2022-07-29
Accepted
2022-07-29 16:58:15
Documents
12
Period of Report
2022-07-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea163597-8k_gamidacell.htm   iXBRL 8-K 59025
  Complete submission text file 0001213900-22-042996.txt   235889

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE gmda-20220727.xsd EX-101.SCH 2968
3 XBRL LABEL FILE gmda-20220727_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE gmda-20220727_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT ea163597-8k_gamidacell_htm.xml XML 3633
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38716 | Film No.: 221121643
SIC: 2836 Biological Products, (No Diagnostic Substances)